Liu S, An L, Yin Z, Lin Y, Ling Z, Deng B, Yu X, Zheng Q, Zhao D, Wu T, Chang AH, Tong C. Five-year outcome of CD19 followed by CD22 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia patients who relapsed after allo-transplantation. Haematologica 2025;110(5):1192-1196; https://doi.org/10.3324/haematol.2024.286534.